Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29018077

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2017 Nov 30
First author
Kumar S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Nov 30;130(22):2359-2360. doi: 10.1182/blood-2017-09-805341.
    note
    Source null
    related pmid
    29191974
    relationship
    Comment in

Authors and identifiers

  1. name
    Kumar S
    type
    Author
  2. name
    Kaufman JL
    type
    Author
  3. name
    Gasparetto C
    type
    Author
  4. name
    Mikhael J
    type
    Author
  5. name
    Vij R
    type
    Author
  6. name
    Pegourie B
    type
    Author
  7. name
    Benboubker L
    type
    Author
  8. name
    Facon T
    type
    Author
  9. name
    Amiot M
    type
    Author
  10. name
    Moreau P
    type
    Author
  11. name
    Punnoose EA
    type
    Author
  12. name
    Alzate S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kumar S
    type
    Author
  2. name
    Kaufman JL
    type
    Author
  3. name
    Gasparetto C
    type
    Author
  4. name
    Mikhael J
    type
    Author
  5. name
    Vij R
    type
    Author
  6. name
    Pegourie B
    type
    Author
  7. name
    Benboubker L
    type
    Author
  8. name
    Facon T
    type
    Author
  9. name
    Amiot M
    type
    Author
  10. name
    Moreau P
    type
    Author
  11. name
    Punnoose EA
    type
    Author
  12. name
    Alzate S
    type
    Author
bibliography ids
  1. nci-bib-508b9daa5ea3f91f9d78b793
book metadata
content sha256
6e6ae3fd4ecc5c89a7941f6a29c0dffce93d9ff79ca98d6da9283343958f81a4
document type
citation
dois
  1. 10.1182/blood-2017-06-788786
electronic publication date
display
2017 Oct 10
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29018077
immutable id
pubmed:29018077@6e6ae3fd4ecc5c89a7941f6a29c0dffce93d9ff79ca98d6da9283343958f81a4
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
22
name
Blood
nlm unique id
7603509
pages
2401-2409
volume
130
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Nov 30;130(22):2359-2360. doi: 10.1182/blood-2017-09-805341.
    note
    Source null
    related pmid
    29191974
    relationship
    Comment in
outcomes validated
false
pmid
29018077
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
298efff2b5c7f06eb43c30d06a873799cf9ee1f51018d9eda0eab0af4c98d66d
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Nov 30
precision
day
year
2017
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29018077/
title
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.

Preserved source evidence · Not medical advice